Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myoadenylate deaminase deficiency.

H H Goebel1, A Bardosi

  • 1Abteilung für Neuropathologie der Universität, Mainz.

Klinische Wochenschrift
|November 2, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PACAP deficiency as a model of aging.

GeroScience·2018
Same author

Disturbed spermatogenic signaling in pituitary adenylate cyclase activating polypeptide-deficient mice.

Reproduction (Cambridge, England)·2017
Same author

Neuronal ceroid lipofuscinosis (NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke dog.

Molecular genetics and metabolism·2016
Same author

Protein aggregation in inclusion body myositis, a sporadic form among protein aggregate myopathies, and in myofibrillar myopathies--a comparative study.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2011
Same author

Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.

Neuropediatrics·2010
Same author

CLN5 mutations are frequent in juvenile and late-onset non-Finnish patients with NCL.

Neurology·2010
Same journal

Klinische Wochenschrift·2020
Same journal

Pathological anatomy of malnutrition.

Klinische Wochenschrift·2010
Same journal

Consequences of chronic malnutrition in the clinical picture of internal diseases.

Klinische Wochenschrift·2010
Same journal

Use of stable isotopes in biology.

Klinische Wochenschrift·2010
Same journal

About applications of radioactive indicators in medicine and physiology.

Klinische Wochenschrift·2010
Same journal

Early diagnosis and assessment of the activity of pulmonary tuberculosis based on serological examinations.

Klinische Wochenschrift·2010
See all related articles

Myoadenylate deaminase (MAD) deficiency, a common muscle enzyme defect, can now be treated with D-ribose. This finding offers hope for patients with this condition and associated neuromuscular disorders.

Area of Science:

  • Biochemistry
  • Enzymology
  • Muscle Physiology

Background:

  • Myoadenylate deaminase (MAD) is crucial for energy production in muscles during intense activity, linking purine nucleotide and citric acid cycles.
  • MAD exhibits higher activity in muscle tissue compared to other organs.
  • MAD deficiency is a frequent enzyme defect in muscle, presenting as an isolated condition or alongside neuromuscular disorders.

Purpose of the Study:

  • To review the significance of myoadenylate deaminase deficiency.
  • To discuss the biochemical and clinical implications of MAD deficiency.
  • To highlight recent therapeutic advancements for primary MAD deficiency.

Main Methods:

  • Enzyme-histochemical detection of MAD.
  • Biochemical analysis of enzyme activity.

Related Experiment Videos

  • Morphological and clinical data assessment.
  • Review of accumulated data over the past decade.

    • Main Results:

    • Myoadenylate deaminase deficiency is a common enzyme defect in muscle.
    • Primary MAD deficiency can be successfully treated with high doses of D-ribose.
    • Secondary MAD deficiency is associated with structural muscle damage in conditions like polymyositis and muscular dystrophy.

    Conclusions:

    • Myoadenylate deaminase deficiency is a significant nosological entity.
    • D-ribose offers a promising treatment for primary MAD deficiency.
    • Understanding MAD deficiency aids in diagnosing and managing various neuromuscular conditions.